FSD Pharma is committed to the pursuit of developing innovative novel biotechnologies to bring advanced neurodegenerative and mental health treatments to market.

Pharmaceutical

FSD Pharma

FSD Pharma's headquarters in Cobourg, Canada

Raza Bokhari

Lakshmi P. Kotra

Shahzad Shah

Sara May

Edward J. Brennan

Sandy Huard

Mallory Loflin

Anthony Durkacz

David Urban

Gerry David

Eric Hoskins

Kevin Harrington

Eleanor Fish

Kwok Chow

Peter K. Stys

Nathan Coyle

Adnan Bashir

Nitin Kaushal

Hance Clarke

Albert H.c. Wong

Joga Gobburu

Mary Melnyk

Mike Zapolin

The Clinical and Regulatory Affairs team at FSD Pharma plays a critical role in the development and approval of innovative therapies for neurodegenerative and mental health conditions. This team is responsible for designing and overseeing clinical trials, ensuring compliance with regulatory requirements, and collaborating with advisory boards to navigate the complexities of drug development, ultimately aiming to bring groundbreaking treatments to market safely and effectively.

Clinical and Regulatory Affairs

The Leadership Team at FSD Pharma drives the strategic vision and operational oversight of the company's innovative biotechnological initiatives. Comprised of industry veterans, this team collaborates to advance the development of cutting-edge treatments for neurodegenerative and mental health conditions, ensuring alignment across the FSD Pharma and FV Pharma divisions while fostering partnerships and guiding clinical research efforts.

Leadership Team

The Pharmaceutical Development team at FSD Pharma is dedicated to advancing innovative biotechnologies aimed at treating neurodegenerative diseases and mental health disorders. This team, led by experienced executives, focuses on researching, formulating, and optimizing pharmaceutical products to ensure they meet regulatory standards and efficacy requirements, ultimately facilitating their successful transition to market.

Pharmaceutical Development

The Investor Relations and Advisory team at FSD Pharma is responsible for managing communication between the company and its investors, ensuring transparency and fostering strong relationships. They provide strategic guidance on financial matters, help articulate the company's vision and progress in biotechnology developments, and work to enhance investor confidence in FSD Pharma's mission to advance treatments for neurodegenerative and mental health disorders.

Investor Relations and Advisory

FSD Pharma

Org chart

Board & advisors

Teams

Clinical and Regulatory Affairs

Leadership Team

Pharmaceutical Development

Investor Relations and Advisory

Offices

FSD Pharma

Org chart

Board & advisors

Teams

Clinical and Regulatory Affairs

Leadership Team

Pharmaceutical Development

Investor Relations and Advisory

Offices

Related companies